American Century Companies Inc Reata Pharmaceuticals Inc Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$24.12 - $39.6 $1.62 Million - $2.66 Million	-67,071 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$25.61 - $110.96 $56,674 - $245,554	2,213 Added 3.41%	67,071 $1.77 Million
Q3 2021 Nov 10, 2021	BUY	$100.0 - $143.02 $2,000 - $2,860	20 Added 0.03%	64,858 $6.53 Million
Q2 2021 Aug 05, 2021	BUY	$78.27 - $151.29 $2.44 Million - $4.72 Million	31,185 Added 92.67%	64,838 $9.18 Million
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $67,106 - $94,560	-712 Reduced 2.07%	33,653 $3.36 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $4,999 - $9,046	49 Added 0.14%	34,365 $4.25 Million
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $21,605 - $37,731	231 Added 0.68%	34,316 $3.34 Million
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $1.08 Million - $1.51 Million	8,558 Added 33.53%	34,085 $5.32 Million
Q1 2020 May 14, 2020	SELL	$124.16 - $247.74 $690,826 - $1.38 Million	-5,564 Reduced 17.9%	25,527 $3.69 Million
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $125,874 - $367,848	1,688 Added 5.74%	31,091 $6.36 Million
Q3 2019 Nov 13, 2019	SELL	$71.26 - $95.75 $178,577 - $239,949	-2,506 Reduced 7.85%	29,403 $2.36 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $6,761 - $8,208	-87 Reduced 0.27%	31,909 $3.01 Million
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $473,743 - $929,139	-9,128 Reduced 22.2%	31,996 $0
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $536,360 - $840,840	11,000 Added 36.52%	41,124 $2.31 Million
Q3 2018 Nov 02, 2018	BUY	$35.64 - $92.06 $1.07 Million - $2.77 Million	30,124 New	30,124 $2.46 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account